hotspot -WSS

hotspot

author：fashion 2025-10-03 00:07:46 - browse：3855

Three boxes of Wegovy stands in a line — coverage from STAT — Steffen Trumpf/picture alliance/Getty Images

WASHINGTON — Novo Nordisk’s newly won permission to market the heart benefits of its obesity drug Wegovy could provide a backdoor way to expand access to the drug for people on Medicare, experts told STAT.

Currently, Medicare is prohibited by law from covering medications for obesity treatment alone. While companies that manufacture wildly popular anti-obesity medications and their allies haven’t been successful in lobbying Congress to change the law, the Food and Drug Administration’s move could give doctors an avenue to prescribe the medications to some Medicare patients.

Wegovy’s new label indicates that the drug can be used to reduce the risk of major heart complications for people who are overweight or obese and have existing heart disease, Novo said in a statement Friday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： 5 takeaways from STAT's examination of Zynex Medical

WSS

Heat wave can put hearts into ‘oxygen debt,' lab experiment shows

It shouldn't be easy to buy synthetic DNA to recreate a deadly virus

H5N1 communication has been strictly for the birds

Heat wave can put hearts into ‘oxygen debt,' lab experiment shows

Apple Watch's A

The system is set up to fail children with medical complexity

entertainment

hotspot

leisure time

Duchenne breakthrough therapy leaves behind pioneering families

Deposition: Sackler embraced plan to conceal OxyContin’s strength

Anesthesiologist group: stop taking Ozempic before surgery

Teladoc has a new CEO, but challenges remain the same

Alkermes shareholders re

My daughter's legacy lives on through her writing, phage therapy

How one medical school became remarkably diverse

Readers discuss the intersection of pregnancy and addiction

Medical records are filled with copy

Use wet bulb globe temperature, not heat index, to protect workers

entertainment

Readout LOUD podcast: brain research, obesity drug sales, Novartis

Study: AI not yet building 'n

Shionogi licenses Pompe disease therapy from Maze Therapeutics

Cigna wins case to block Amy Bricker's move to CVS

Stephen Quake on the Chan Zuckerberg quest to conquer disease

The system is set up to fail children with medical complexity

focus

hotspot

focus

focus